Literature DB >> 31316751

A theoretical model of temperate phages as mediators of gut microbiome dysbiosis.

Derek M Lin1, Henry C Lin1,2.   

Abstract

Bacteriophages are the most prominent members of the gut microbiome, outnumbering their bacterial hosts by a factor of 10. Phages are bacteria-specific viruses that are gaining attention as highly influential regulators of the gut bacterial community. Dysregulation of the gut bacterial community contributes to dysbiosis, a microbiome disorder characterized by compositional and functional changes that contribute to disease. A role for phages in gut microbiome dysbiosis is emerging with evidence that the gut phage community is altered in dysbiosis-associated disorders such as colorectal cancer and inflammatory bowel disease. Several recent studies have linked successful fecal microbiota transplantation to uptake of the donor's gut phage community, offering some insight into why some recipients respond to treatment whereas others do not. Here, we review the literature supporting a role for phages in mediating the gut bacterial community, giving special attention to Western diet dysbiosis as a case study to demonstrate a theoretical phage-based mechanism for the establishment and maintenance of dysbiosis.

Entities:  

Keywords:  Bacteriophage; dysbiosis; fecal microbiota transplant; gut; microbiome; phage; prophage-encoded genes; virome; western diet

Mesh:

Year:  2019        PMID: 31316751      PMCID: PMC6611130          DOI: 10.12688/f1000research.18480.1

Source DB:  PubMed          Journal:  F1000Res        ISSN: 2046-1402


Introduction

Insights into the relationship between diet and the gut microbiome have significantly advanced our understanding of nutrition as a mediator of health and disease. The influence of the Western diet specifically on dysbiosis in the gut bacterial community is well established [1]. Conspicuously lacking from this body of research is a fundamental understanding of the gut virome, sometimes referred to as the “dark matter” of the microbiome [2]. It has long been known that the virome harbors genes for antibiotic resistance and bacterial toxins [3, 4], contributing to the virulence of clinically relevant bacterial pathogens [5, 6]. Emerging evidence implicates an altered gut virome in colorectal cancer, inflammatory bowel disease, and other states associated with microbiome dysbiosis [7– 10]. The role of the virome, whether as cause or consequence of dysbiosis, is unclear.

Gut microbiome dysbiosis

Gut microbiome dysbiosis broadly encompasses the various states of perturbed gut microbial community composition associated with disease or disorder in the host. In a healthy gut environment, the resident (commensal) gut bacteria (that is, symbionts) are non-pathogenic. A healthy gut microbiota–host interaction is a mutualism in which gut bacteria thrive in the gastrointestinal environment of the host while providing the host with multiple benefits through metabolism, immune system development, and protection from pathogens [11]. During dysbiosis, the homeostatic balance of this symbiosis shifts, disrupting the beneficial nature of the relationship and contributing to disease states. In this setting, otherwise beneficial gut symbionts may transition to a state of pathogenicity (that is, pathobionts). Dysbiosis is implicated in the etiology of numerous clinical disorders ranging from those involving the digestive tract, such as inflammatory bowel disease and non-alcoholic steatohepatitis, to those outside the digestive tract, such as atherosclerotic cardiovascular disease and autism [12– 15].

The gut virome

Evidence on the role of gut viruses during dysbiosis is limited. The predominant members of the gut virome are bacteria-specific viruses called bacteriophages (phages). Phages are most commonly associated with phage therapy, a practice of administering lytic phages to control bacterial pathogens (for example, Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa) [16]. About 10 14 viruses, comprised of about 1200 virotypes, reside in the gut [17]; this population is 10 times as abundant as gut bacteria but comparable in diversity [18, 19]. Contemporary studies of the gut bacterial community rely on next-generation sequencing of the universal 16s rRNA bacterial gene, which provides a compositional readout of the microbiome. This approach is not possible with phages as they lack a conserved phylogenetic marker [20], one of many challenges in phage research. Even the gold standard for studying phage communities, viral metagenomics, is limited by the lack of a genomic library to compare against the enormous diversity of uncharacterized phage genes collectively referred to as “viral dark matter” [2]. Advances in gut phage research have demonstrated a role for phages as agents of compositional change in the gut microbial community [21, 22]. Phages exert enormous evolutionary pressure on microbial communities by lysing their bacterial hosts or by mediating gene transfer [23]. In oceanic surface waters, phage-mediated lysis leads to the death of 20 to 40% of the total bacterial population every 24 hours [24]. In the gut, phages are primarily temperate and able to incorporate into the bacterial chromosome as latent prophages, thereby reproducing with the bacterial host (that is, the lysogenic cycle); prophages then may produce phage progeny by inducing the lytic cycle ( Figure 1) [20]. Temperate phages also have the option of reproducing by entering the lytic cycle directly and immediately lysing their bacterial host. About half of all sequenced bacterial genomes in the GenBank database contain at least one prophage, and some species can harbor up to 15 [25]. Prophages are intimately linked to bacterial resilience and function, encoding genes for metabolism, antibacterial resistance, and toxin production (for example, shiga toxin production), thereby providing fitness benefits for the bacterial host [6, 9]. Prophages further enhance fitness in their bacterial hosts by preventing infection from other phages (that is, superinfection exclusion) and by lysing competing bacteria (that is, “kill-the-relative”) [26, 27]. Some phage-encoded genes are required for commensal gut bacteria to form a mutualism with their host [28]; conversely, phage-encoded virulence factors promote pathogenic behavior in their host [6, 29]. These findings are highly relevant to the study of gut microbiome dysbiosis, which can be characterized by the transition of commensal bacteria from symbiont to pathobiont. The transition to dysbiosis is multifactorial and once established it becomes difficult to treat [30].
Figure 1.

Reproductive life cycles of a temperate phage.

Temperate phages can reproduce via both lytic and lysogenic cycles. The decision as to which cycle gets induced depends on environmental factors. This simplified version of phage life cycles demonstrates how the cycles are intertwined.

Reproductive life cycles of a temperate phage.

Temperate phages can reproduce via both lytic and lysogenic cycles. The decision as to which cycle gets induced depends on environmental factors. This simplified version of phage life cycles demonstrates how the cycles are intertwined.

A role for phages in mediating dysbiosis

Dysbiosis is associated with an increased abundance and richness of the mucosal temperate phage population [7– 9, 31, 32]. Prophages in the gut are spontaneously induced into the lytic cycle at a modest baseline level [33]. Large-scale induction typically requires environmental stressors that cause a community-wide “SOS response” in the bacterial hosts [34]. The SOS response is triggered by DNA damage in the bacterial chromosome [35], essentially signaling to the prophage that the bacterial host is no longer suitable. The prophage reacts by inducing the lytic cycle to produce a new population of phage progeny, which seek out new hosts to infect. The inflamed gut is associated with an upregulated SOS response in resident gut bacteria [36], loss of phage diversity [32], and elevated levels prophage induction [37]. Elevated prophage induction is a mechanism of horizontal gene transfer between bacterial hosts, increasing rates of genetic recombination and diversification of phage-encoded genes [38]. This process has been found to drive the evolution of bacterial pathogens by expanding the reservoir of phage-encoded genes for virulence factors and antibiotic resistance [5, 37]. In the setting of an infection by enteric pathogens such as shiga toxin–producing E. coli, antibiotics that trigger the SOS response activate shiga toxin synthesis through the phage induction pathway; this can lead to diarrhea, hemorrhagic colitis, hemolytic-uremic syndrome, and even death [6]. Prophages encode virulence factors for other clinically relevant pathogens, including Vibrio cholerae, S. aureus, Corynebacterium diphtheriae, and Clostridium botulinum [29] . In addition to directly encoding genes for toxins, phage genes can indirectly upregulate production of bacterial toxins and can influence adhesion, colonization, and invasion [39]. Within the gut environment, phages are suspected of mediating diversification of the non-pathogenic, commensal microbial community [40]. Temperate phages are theorized to act on the commensal microbiota via “community shuffling”, whereby prophage induction in response to SOS-triggering stressors may increase the pathobiont-to-symbiont ratio observed during dysbiosis [41]. Lending support to this theory is the finding that changes to gut phage community composition precede the onset of type 1 diabetes in children [42]. Furthermore, recovery from Clostridium difficile dysbiosis after fecal microbiota transplantation (FMT) is associated with an uptake of the donor phage community [43– 45]. Collectively, there is strong evidence of a role for gut phages in numerous disease states associated with gut microbiome dysbiosis.

Western diet dysbiosis as a case study

A Western diet, characterized by a high-fat, high-sugar, and low-fiber intake, is one of the most clinically important disruptors of the gut microbiome. The substantial body of literature on the Western diet provides an ideal case study for this theoretical model, illustrating the potential role of phages in mediating dysbiosis (a graphical representation of this model can be found in Figure 2). It should be noted that a “Western” diet is often generalized as “high fat” when it has been shown that the type of fat is an important factor in the onset of dysbiosis and disease [46, 47]. Indeed, a Western diet can be classified differently but is commonly associated with high levels of either n-6 polyunsaturated fats or saturated fats [1].
Figure 2.

Theoretical model for phage-mediated dysbiosis.

Prophages can drive otherwise commensal bacterial hosts (symbionts) to behave pathogenically (pathobionts) when exposed to environmental stressors, such as those associated with a Western diet. Phage-encoded genes support bacterial mechanisms for bacterial survival at the cost of the human host. The pathogenic behavior of these resident gut microbes promotes inflammation in the intestinal epithelium, which perpetuates the state of environmental stress and persistent dysbiosis.

Theoretical model for phage-mediated dysbiosis.

Prophages can drive otherwise commensal bacterial hosts (symbionts) to behave pathogenically (pathobionts) when exposed to environmental stressors, such as those associated with a Western diet. Phage-encoded genes support bacterial mechanisms for bacterial survival at the cost of the human host. The pathogenic behavior of these resident gut microbes promotes inflammation in the intestinal epithelium, which perpetuates the state of environmental stress and persistent dysbiosis. In a Western diet–induced mouse model of obesity, adverse effects include glucose intolerance and fatty liver, both of which improve after treatment with norfloxacin and ampicillin [48], demonstrating the role of an antibiotic-sensitive microbiome. Antibiotic treatment reverses the state of increased intestinal permeability, a common outcome of a Western diet that results in elevated plasma concentration of bacterial endotoxins [49]. These findings suggest that a Western diet can disrupt homeostatic balance in the gut microbiome, promoting a state of increased intestinal permeability, increased endotoxin absorption, and endotoxemia. The endotoxin, in turn, drives the immune response of the host, thereby producing inflammation, glucose intolerance, and the other characteristic features of metabolic syndrome. A Western diet is distinguished by not only its high lipid content but also its low availability of fiber. Deprived of fiber from the diet, the gut microbiota compensates by foraging host glycans from the epithelial mucus layer [50]. Whether phages mediate genes related to glycan foraging has yet to be studied. A healthy mucus layer is a protective boundary separating the sensitive host epithelium from the pro-inflammatory contents of the intestinal lumen (for example, bacterial endotoxins). Degradation of the mucus layer by glycan-foraging bacteria depletes this protection, bringing luminal bacteria closer to the epithelium, thus promoting inflammation and increased intestinal permeability [51, 52]. A more permeable intestinal lining is hypothesized to allow more oxygen from the bloodstream to enter the normally anoxic intestinal lumen [53], inflicting oxidative stress on obligate anaerobes in the gut [54]. This idea is supported by the finding that oxygen respiration becomes a dominant metabolic signature in mouse models of colitis [55]. Using the phosphorescence quenching method, Albenberg et al. (2014) showed that there is an oxygen gradient radially in the gut lumen whereby the oxygen concentration is highest near the mucosa [56]. Accordingly, the composition of the gut bacterial community is organized radially, and mucosally associated bacteria are the most oxygen-tolerant [57]. It is now appreciated that the intestinal barrier does not simply have two states, impermeable and permeable, but rather there exists degrees of permeability. However, there is a consensus that increased permeability associated with bacterial translocation and immune activation is harmful and leads to chronic inflammation [11, 53]. A change in oxygen concentration may also affect the gut phage population as oxidative stress is a trigger of the SOS response and can induce prophages to enter the lytic cycle. In support of this hypothesis is a study by Kim and Bae (2016), who demonstrated that a Western diet expands phage-encoded genes for oxidative tolerance [9]. It is unlikely that oxidative stress on commensal bacteria is solely responsible for inducing gut phages, as the metabolic by-products of a Western diet have also been shown to trigger prophage induction [58]. A Western diet has been found to increase the population density of phages in the gut mucosa and expand the reservoir of phage-encoded genes for phage reproduction [9]. Higher rates of temperate phage infection can cause pathogenicity in commensal gut bacteria by disrupting the function of bacterial genes [29]. Systematic disruption of bacterial genes by phages may have the potential to drive the entire gut microbial community toward a state of increased pathogenic potential (that is, dysbiosis). Whether other disruptors of the gut microbiome—including antibiotic therapy, inflammation, exposure to anesthesia, surgery or other traumas, immune deficiency, and exposure to toxins—exert their effects on the microbiome via its phage population remains to be tested. Most laboratory observations suggest that phages generally have a narrow host range (all bacteria a phage can infect) [23], although recent evidence suggests that phages have a much broader host range in the gut than what has been observed in vitro [59, 60]. Stressors that induce prophages (for example, antibiotic treatment) consequently broaden phage host range and expand the reservoir of phage-encoded genes for surviving the stressor (for example, antibiotic resistance genes) [5]. Diet is a potential regulator of prophage induction among commensal gut bacteria [59], and unregulated prophage induction may be responsible for disturbing the homeostatic relationship between microbiome and host. Since perturbation of the gut environment by a Western diet upregulates phage-encoded genes for lipid metabolism and oxidative tolerance [9], it can be reasonably postulated that these phages likely confer a competitive advantage to their bacterial hosts in a gut environment with higher availability of lipids and increased levels of luminal oxygen. Phages with the combination of broad host range and genes for bacterial host fitness may have a substantial competitive advantage in the gut microbial community, thereby propagating these genes across taxonomically distinct bacterial species within the microbiota and increasing competition for limited resources such as host glycans from the mucus layer. The microbiome composition during Western diet dysbiosis shifts with an expansion of bacteria in the phyla Proteobacteria and Firmicutes [61]; Proteobacteria specifically are associated with numerous dysbioses, intestinal barrier dysfunction, and low-grade inflammation [57]. The majority of gut prophages are found in the genomes of these two phyla [59], and there is a positive correlation between viral content and Firmicutes in the feces during obesity [62]. There is clear evidence that prophages can help make the decision for their bacterial hosts to act as either symbionts or pathobionts [6, 28] and consumption of a Western diet may influence that decision. Outlined above is one possible mechanism for the evolution of a phage community that promotes pathogen-like behavior in otherwise commensal gut bacteria through elevated prophage induction, wherein bacterial survival may come at a cost to the human host. This theoretical model also takes into account the loss of phage diversity observed in response to gut microbiome perturbations, which may be responsible for the persistence of dysbiosis and resistance to clinical treatment. It is worth noting that our proposed model is not mutually exclusive with other mechanisms that may lead to Western diet–associated dysbiosis, such as those involving host metabolism in response to specific dietary fats [47] or host genetic factors [63, 64].

Moving forward

As demonstrated by Howe et al. (2016), a Western diet mouse model reduces both bacterial and phage diversity [65]. After mice are transitioned back to a standard diet, diversity of the bacterial community returns to pre–Western diet levels whereas the diversity of the phage community remains low. It is possible that dietary disturbances permanently alter phage diversity as well as the functional nature of the phage-encoded gene reservoir; the long-term impacts of this lost diversity are unknown. Treatment of dysbiosis may be contingent on re-establishing a healthy phage community. Recent developments in clinical FMT therapy have identified an association between successful treatment of C. difficile infection and uptake of the donor’s fecal phage community by the FMT recipient [43, 45]. A clinical study found that administration of a bacteria-depleted fecal filtrate (phages retained) was sufficient for treatment of C. difficile infection and transition of the recipient phage community toward that of the donor [44]. In an ulcerative colitis mouse model, FMT responders had reduced populations of mucosal phages compared with non-responders [31]. The composition of the donor’s phage community has yet to be considered an important factor for FMT. For that matter, the recipient’s diet has also not been considered. Gut phages heavily influence the composition of the gut microbiota and in turn its relationship with the human host. Much research still needs to be carried out to determine how the phage community responds to perturbation and contributes to the establishment, maintenance, and remediation of dysbiosis.

Abbreviation

FMT, fecal microbiota transplantation
  64 in total

1.  Metagenomic analyses of an uncultured viral community from human feces.

Authors:  Mya Breitbart; Ian Hewson; Ben Felts; Joseph M Mahaffy; James Nulton; Peter Salamon; Forest Rohwer
Journal:  J Bacteriol       Date:  2003-10       Impact factor: 3.490

Review 2.  Bacteriophage control of bacterial virulence.

Authors:  Patrick L Wagner; Matthew K Waldor
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

Review 3.  Phages and the evolution of bacterial pathogens: from genomic rearrangements to lysogenic conversion.

Authors:  Harald Brüssow; Carlos Canchaya; Wolf-Dietrich Hardt
Journal:  Microbiol Mol Biol Rev       Date:  2004-09       Impact factor: 11.056

4.  Dysbiosis in inflammatory bowel disease: a role for bacteriophages?

Authors:  P Lepage; J Colombet; P Marteau; T Sime-Ngando; J Doré; M Leclerc
Journal:  Gut       Date:  2008-03       Impact factor: 23.059

Review 5.  The bacterial LexA transcriptional repressor.

Authors:  M Butala; D Zgur-Bertok; S J W Busby
Journal:  Cell Mol Life Sci       Date:  2009-01       Impact factor: 9.261

6.  Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice.

Authors:  X Zhang; A D McDaniel; L E Wolf; G T Keusch; M K Waldor; D W Acheson
Journal:  J Infect Dis       Date:  2000-02       Impact factor: 5.226

7.  Dysbiosis in inflammatory bowel disease.

Authors:  C P Tamboli; C Neut; P Desreumaux; J F Colombel
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

8.  Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice.

Authors:  Patrice D Cani; Rodrigo Bibiloni; Claude Knauf; Aurélie Waget; Audrey M Neyrinck; Nathalie M Delzenne; Rémy Burcelin
Journal:  Diabetes       Date:  2008-02-27       Impact factor: 9.461

9.  Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice.

Authors:  Mathieu Membrez; Florence Blancher; Muriel Jaquet; Rodrigo Bibiloni; Patrice D Cani; Rémy G Burcelin; Irène Corthesy; Katherine Macé; Chieh Jason Chou
Journal:  FASEB J       Date:  2008-03-07       Impact factor: 5.191

10.  Transposition of R factor genes to bacteriophage lambda.

Authors:  D E Berg; J Davies; B Allet; J D Rochaix
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

View more
  9 in total

Review 1.  Manipulation of Gut Microbiota as a Key Target for Crohn's Disease.

Authors:  Reem Rashed; Rosica Valcheva; Levinus A Dieleman
Journal:  Front Med (Lausanne)       Date:  2022-06-16

Review 2.  The gut virome in inflammatory bowel disease pathogenesis: From metagenomics to novel therapeutic approaches.

Authors:  Federica Ungaro; Luca Massimino; Silvia D'Alessio; Silvio Danese
Journal:  United European Gastroenterol J       Date:  2019-09-27       Impact factor: 4.623

3.  The dark side of the gut: Virome-host interactions in intestinal homeostasis and disease.

Authors:  Yuhao Li; Scott A Handley; Megan T Baldridge
Journal:  J Exp Med       Date:  2021-05-03       Impact factor: 14.307

Review 4.  Roles of Gut Bacteriophages in the Pathogenesis and Treatment of Inflammatory Bowel Disease.

Authors:  Lingling Qv; Sunbing Mao; Yongjun Li; Jia Zhang; Lanjuan Li
Journal:  Front Cell Infect Microbiol       Date:  2021-11-25       Impact factor: 5.293

Review 5.  Going Beyond Bacteria: Uncovering the Role of Archaeome and Mycobiome in Inflammatory Bowel Disease.

Authors:  Yashar Houshyar; Luca Massimino; Luigi Antonio Lamparelli; Silvio Danese; Federica Ungaro
Journal:  Front Physiol       Date:  2021-12-06       Impact factor: 4.566

6.  Morphological and Genetic Characterization of Eggerthella lenta Bacteriophage PMBT5.

Authors:  Sabrina Sprotte; Torben S Rasmussen; Gyu-Sung Cho; Erik Brinks; René Lametsch; Horst Neve; Finn K Vogensen; Dennis S Nielsen; Charles M A P Franz
Journal:  Viruses       Date:  2022-07-22       Impact factor: 5.818

Review 7.  The Human Gut Phageome: Origins and Roles in the Human Gut Microbiome.

Authors:  Eleanor M Townsend; Lucy Kelly; George Muscatt; Joshua D Box; Nicole Hargraves; Daniel Lilley; Eleanor Jameson
Journal:  Front Cell Infect Microbiol       Date:  2021-06-04       Impact factor: 5.293

Review 8.  Gut Microbiota beyond Bacteria-Mycobiome, Virome, Archaeome, and Eukaryotic Parasites in IBD.

Authors:  Mario Matijašić; Tomislav Meštrović; Hana Čipčić Paljetak; Mihaela Perić; Anja Barešić; Donatella Verbanac
Journal:  Int J Mol Sci       Date:  2020-04-11       Impact factor: 5.923

Review 9.  Phages in the Gut Ecosystem.

Authors:  Michele Zuppi; Heather L Hendrickson; Justin M O'Sullivan; Tommi Vatanen
Journal:  Front Cell Infect Microbiol       Date:  2022-01-04       Impact factor: 5.293

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.